Back to top

stock-price-movement: Archive

Zacks Equity Research

Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher

Elicio Therapeutics (ELTX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

ELTXPositive Net Change

Zacks Equity Research

Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 50-Day Moving Average

Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?

NTLAPositive Net Change

Zacks Equity Research

Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Adma Biologics (ADMA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

ADMANegative Net Change

Zacks Equity Research

Here's Why Momentum in CHOW TAI FOOK (CJEWY) Should Keep going

CHOW TAI FOOK (CJEWY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

CJEWYPositive Net Change

Zacks Equity Research

Recent Price Trend in Nomad Foods (NOMD) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Nomad Foods (NOMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

NOMDPositive Net Change

Zacks Equity Research

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?

Zealand Pharma AS (ZLDPF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ZLDPFPositive Net Change AKYANegative Net Change

Zacks Equity Research

Andritz (ADRZY) Upgraded to Strong Buy: Here's Why

Andritz (ADRZY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADRZYPositive Net Change

Zacks Equity Research

All You Need to Know About SkyWest (SKYW) Rating Upgrade to Buy

SkyWest (SKYW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SKYWPositive Net Change

Zacks Equity Research

Stagwell (STGW) Moves to Buy: Rationale Behind the Upgrade

Stagwell (STGW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STGWNegative Net Change

Zacks Equity Research

Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know

Puma Biotech (PBYI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PBYIPositive Net Change

Zacks Equity Research

All You Need to Know About Carpenter (CRS) Rating Upgrade to Buy

Carpenter (CRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CRSNegative Net Change

Zacks Equity Research

All You Need to Know About Five9 (FIVN) Rating Upgrade to Buy

Five9 (FIVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FIVNNegative Net Change

Zacks Equity Research

All You Need to Know About Ponce Financial (PDLB) Rating Upgrade to Strong Buy

Ponce Financial (PDLB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PDLBNegative Net Change

Zacks Equity Research

All You Need to Know About Humacyte, Inc. (HUMA) Rating Upgrade to Buy

Humacyte, Inc. (HUMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HUMAPositive Net Change

Zacks Equity Research

TaskUs (TASK) Moves to Buy: Rationale Behind the Upgrade

TaskUs (TASK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TASKNegative Net Change

Zacks Equity Research

Spotify (SPOT) Upgraded to Strong Buy: What Does It Mean for the Stock?

Spotify (SPOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SPOTPositive Net Change

Zacks Equity Research

CI&T (CINT) Surges 6.0%: Is This an Indication of Further Gains?

CI&T (CINT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

CINTPositive Net Change VERXNegative Net Change

Zacks Equity Research

Strength Seen in Okta (OKTA): Can Its 7.4% Jump Turn into More Strength?

Okta (OKTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

OKTANegative Net Change FTNTNegative Net Change

Zacks Equity Research

Affirm Holdings (AFRM) Recently Broke Out Above the 50-Day Moving Average

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

AFRMNegative Net Change

Zacks Equity Research

Recent Price Trend in GBank Financial Holdings Inc. (GBFH) is Your Friend, Here's Why

GBank Financial Holdings Inc. (GBFH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

GBFHNo Net Change

Zacks Equity Research

West Japan Railway (WJRYY) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, West Japan Railway (WJRYY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

WJRYYNegative Net Change

Zacks Equity Research

Here's Why 'Trend' Investors Would Love Betting on Sabesp (SBS)

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

SBSPositive Net Change

Zacks Equity Research

Paranaense de Energia (ELP) Is a Great Choice for 'Trend' Investors, Here's Why

Paranaense de Energia (ELP) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

ELPPositive Net Change

Zacks Equity Research

Here's What Could Help Capcom (CCOEY) Maintain Its Recent Price Strength

Capcom (CCOEY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

CCOEYPositive Net Change

Zacks Equity Research

Here's Why Momentum in DBV Technologies (DBVT) Should Keep going

DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

DBVTNegative Net Change